<!-- H. S. White et al.  -->
![](https://web-api.textin.com/ocr_image/external/140f367f2d444aa7.jpg)


| e a l u  u  s O a Y  I e a u o a l A a d e a a u i J O  x e p u l  a A a 0 J d  p u e  A A I e  u e s I n A u o a I u Y ·l e l d e L  | a u l u U A S U I X O 0 J C l d  | ( O  8 5 B 6 l /) 8 E %a ld ( 8 S B 6 l /) 8 %E a Id  | 3 AN L L S一さn O . 0 &gt;0 &gt;p  A a ( ( s S E o . 6 Z c 0 p  a 0 6 -0 D 0 -l 0 a S I 2 9 1 Z 1 -1 6 7 -6 S ) 0 S ) 6 s m . Z d 7 5 6  6 7 f E M e 9 L . S7 二8 . u 9 0 1 l A &gt; e u a ( u （（( p o B すS y 0 . 1 寸サs u 6 e E す7 o 0 -1 o J ー6 . す一-8 1 t d  0 7 E ）7 U 9 ) ) O ）Z  S E u ．E L 9 0 0  S 2 Z L 8 E t u R u 1 I u e  O 8 Z1 0  $F-{\lambda }$ $150$1 . . 1 8 0 s  |
| -- | -- | -- | -- |
| e a l u  u  s O a Y  I e a u o a l A a d e a a u i J O  x e p u l  a A a 0 J d  p u e  A A I e  u e s I n A u o a I u Y ·l e l d e L  | a u I I n n C I S l O z e J n e e u e l /A a u a d  | ( O  8 s B e l /) 8 E %a id ( O 8 S B 6 /) 8 。u a  | u  ( U （( ( A 8 o 十6 S I . I ．m E C L 9 I 8 e 1 すす-x -6 o S 0 o J ．のS t ' d 9 7 E o Z  7 ) ) J ) O u 6 0 n s  L . . 6 a 6 u 0 s 0 0 L S 5 S  I 1 E u I u Z ZS 6 寸m $Fe$. Z . b 0 &gt;a u U a ( o ( （( p I 6 6 L I t u ' z S N e e S I I  -1 1 --0 -s B I 6 Z 1 u 8 J d ' p  5 l ）) o )  ) o Z 9 m l 0 u S . 0  l 8 e  t O S S 0 一1 a S s o  |
| e a l u  u  s O a Y  I e a u o a l A a d e a a u i J O  x e p u l  a A a 0 J d  p u e  A A I e  u e s I n A u o a I u Y ·l e l d e L  | 1 s e  S I N 1 s a  P o J o 1 o 8  | ( C  8 B s 5 y 6 l /) 8 E %a ( C  8 B 5 6 l /) B %E a L Q山 | p  a Z 6 . Z . 91 十0 Z 9 S 0 S A ＞a L 퐁U ( ( o 으. 8 1 . ( S s ( 8 E I I s 1 0 7 S e o -1 --0 n s -0 L J t 7 1 s d a 9 Z  l l こ) o e ) ) ) a u I S S 8 L  E S 6 . Z 0 u 1 0 0 I . X 1 E u  ( ( ( ( 0 I 6 O S 8 8 8 S 0 . Z . 7 S 8 E 0 L 1 t t s 0 s N ' 1 ----L o . .  &gt;S :8 6 E S s 7 9 S 0 Z 5 :7 9 9 ) 8    ' n 0 ) ) ) u u u p s S 0 8 . 8 o o o  . A 5 . s 0 p u 1 음9 6 9 Z すす1 e a t e a d 0 o o l J J J d e I a  d  d  d a a I p u u u n I u u P U Q u n n I l J e u n e O e :I u u u u a e X u u u  P a A O o n I I I G u u u J s x x x U e e d o e E E Y Y n r u e u Z N I A d d A 山o e  |


(0a90aL oaeJ) xapul aNaod id PuE SleuIue 80suI aulod pue peJlsap au aCnpoJd o peuInbeJ

# Pentylenetetrazol-induced seizure test

Rank order for relative potencies of the intraperitoneal administration of AEDs in the pentylenetetrazol-induced clonic seizure test in mice was phenobarbital &gt; rufinamide &gt;&gt;valproate = ethosuximide&gt;&gt;phenytoin (Table 1).Phenytoin was ineffective up to a dose of 300 mg/kg. In slight contrast, the rank order for relative anticonvulsant potency in this test with oral administration in mice was phenobarbital&gt; rufinamide &gt; ethosuximid valproate &gt;&gt;&gt;phenytoin(Table 2).

Oral rufinamide(≥1,000mg/kg) and phenytoin (800mg/kg) did not inhibit pentylenetetrazol-induced seizures in rats (Table 3). Phenobarbital achieved the best anticon-vulsive potency of the remaining three AEDs.

# Bicuculline-,picrotoxin-, and strychnine-induced seizure tests in mice

Intraperitoneal rufinamide was effective at nontoxic doses in the bicuculline and picrotoxin clonic seizure tests(ED50\~50-75 mg/kg) and showed partial protec-tion from strychnine-induced tonic seizures (37.5% pro-tection; Table 1). Overall, the general order of potency in these chemically induced seizure tests was phenobarbi-tal≥rufinamide&gt;&gt;Valproate=thosuximide&gt; pheny-toin (Table 1). In the strychnine-induced tonic seizure test,phenytoin had the lowest ED50value,suggesting the great-est potency. However, it is important to note that 50% pro-tection was the maximum achieved with this AED. Pheny-toin failed to provide protection against bicuculline-and picrotoxin-induced clonic seizures in mice.

# Evaluation of behavioral toxicity in mice

The median toxic dose of intraperitoneal rufinamide $(TD_{50})$in the rotorod test of behavioral impairment was 500-1,000 mg/kg.The TD50for rufinamide was higher than that for comparator AEDs (Table 1), indicating a lower toxicity. Higher doses of rufinamide were not as-sessed due the low ED50values and high protective index (&gt;40).

Neurological side effects of very high-dose intraperi-toneal rufinamide (1,000 mg/kg,$n=2;ED_{50}$15-100mg/kg) included decreased motor activity, ataxia,muscle relaxation,decreased respiration, and death (one animal died; the other appeared normal). Higher doses of the com-parator drugs induced increased side effects$(2\times TD_{50})$and resulted in death (all animals) in 3-24 h$(\times TD_{50}.$The safety ratio for rufinamide in mice (T$D_{3}/ED_{97}>19.2$[intraperitoneal] and &gt;23.8 [oral]) was consistently greater than for phenytoin, phenobarbital, and valproate (Table 4).

The median dose of intraperitoneal rufinamide required to produce loss of righting reflex in mice (HI$D_{50})$was &gt;500ad&lt;1,,000mg/kg (Table 5). Rufinamide had a nu-merically greater HD50 value than phenytoin or phenobar-bital (HD50 values of 178 and 135 mg/kg, respectively).Rufinamide, ethosuximide, and valproate had comparable

Epilepsia, 49(7):1213-1220,2008

doi:10.1111/j.1528-1167.2008.01552.x

